USOR 19105

Trial Information

A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating The Efficacy And Safety Of Gdc-0077 Plus Palbociclib And Fulvestrant Versus Placebo Plus Palbociclib And Fulvestrant In Patients With Pik3ca-Mutant, Horomone Receptor-Positive, Her2-Negative Locally Advanced Or Metastatic Breast Cancer

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at 877-664-7724

Quality Care Close to Home


View our locations on map!

Sign Up Today For Our E-Newsletter

  • This field is for validation purposes and should be left unchanged.
United in Healing with The US Oncology Network - Maryland Oncology Hematology